Akhtar, N.; Baig, M.W.; Haq, I.-u.; Rajeeve, V.; Cutillas, P.R.
Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells. Biomedicines 2020, 8, 333.
https://doi.org/10.3390/biomedicines8090333
AMA Style
Akhtar N, Baig MW, Haq I-u, Rajeeve V, Cutillas PR.
Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells. Biomedicines. 2020; 8(9):333.
https://doi.org/10.3390/biomedicines8090333
Chicago/Turabian Style
Akhtar, Nosheen, Muhammad Waleed Baig, Ihsan-ul Haq, Vinothini Rajeeve, and Pedro Rodriguez Cutillas.
2020. "Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells" Biomedicines 8, no. 9: 333.
https://doi.org/10.3390/biomedicines8090333
APA Style
Akhtar, N., Baig, M. W., Haq, I.-u., Rajeeve, V., & Cutillas, P. R.
(2020). Withanolide Metabolites Inhibit PI3K/AKT and MAPK Pro-Survival Pathways and Induce Apoptosis in Acute Myeloid Leukemia Cells. Biomedicines, 8(9), 333.
https://doi.org/10.3390/biomedicines8090333